医药政策法规
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-29)
- (2023-08-28)
- (2023-08-28)
- (2023-08-28)
- (2023-08-28)
- (2023-08-28)
- (2023-08-25)
- (2023-08-25)
- (2023-08-25)
- (2023-08-25)
- (2023-08-25)
- (2023-08-25)
- (2023-08-25)
- (2023-08-24)
- (2023-08-24)
- (2023-08-24)
- (2023-08-23)
- (2023-08-23)
- (2023-08-23)
- (2023-08-23)
- (2023-08-23)
- (2023-08-23)
- (2023-08-23)
- (2023-08-22)
- (2023-08-22)
- (2023-08-22)
- (2023-08-22)
- (2023-08-22)
- (2023-08-22)
- (2023-08-21)
- (2023-08-21)
- (2023-08-21)
- (2023-08-21)
- (2023-08-18)
- (2023-08-18)
- (2023-08-18)
《神经元》:γ分泌酶抑制剂为何不能解决阿尔茨海默病痛点?斯坦福科学家发现,长期抑制γ分泌酶会通过降低神经元胆固醇水平损害突触功能
(2023-08-17)- (2023-08-17)
- (2023-08-17)
- (2023-08-17)
- (2023-08-17)
- (2023-08-16)
- (2023-08-16)
- (2023-08-15)
- (2023-08-15)
- (2023-08-15)
- (2023-08-15)
- (2023-08-15)
- (2023-08-14)
- (2023-08-14)
- (2023-08-14)
- (2023-08-14)